BlackRock
ANRO icon

BlackRock’s Alto Neuroscience ANRO Stock Holding History

BlackRock’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15M Buy
666,188
+58,314
+10% +$1.08M ﹤0.01% 3251
2025
Q4 		$10.8M Buy
607,874
+239,995
+65% +$3.02M ﹤0.01% 3423
2025
Q3 		$1.48M Sell
367,879
-193,969
-35% -$643K ﹤0.01% 4187
2025
Q2 		$1.24M Sell
561,848
-897,328
-61% -$2.14M ﹤0.01% 4190
2025
Q1 		$3.15M Sell
1,459,176
-20,838
-1% -$74.6K ﹤0.01% 3836
2024
Q4 		$6.26M Buy
1,480,014
+34,280
+2% +$214K ﹤0.01% 3634
2024
Q3 		$16.5M Buy
1,445,734
+874,810
+153% +$10.7M ﹤0.01% 3161
2024
Q2 		$6.1M Buy
570,924
+429,356
+303% +$5.59M ﹤0.01% 3617
2024
Q1 		$2.17M Buy
+141,568
New +$2.22M ﹤0.01% 3975

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return